Valeant fails to satisfy investors in ‘female viagra’
Sprout shareholders say company has set price too high, not marketing pill properly
Sprout shareholders say company has set price too high, not marketing pill properly
Disappointed Valeant expected to raise cash and stock offer to drive through merger of companies with significant overlap of shareholders
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices